Immune Signatures of Treatment-Resistant Schizophrenia: A FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Study

Treatment-resistant schizophrenia (TRS) affects around 30% of patients with schizophrenia (SZ) resulting in poor functioning, relapses, and reduced quality of life. Convergent findings show that inflammation could contribute to resistance. We thus search for immune signatures of patients with TRS/ul...

Descripción completa

Detalles Bibliográficos
Autores principales: Leboyer, Marion, Godin, Ophélia, Terro, Emilie, Boukouaci, Wahid, Lu, Ching-lieng, Andre, Myrtille, Aouizerate, Bruno, Berna, Fabrice, Barau, Caroline, Capdevielle, Delphine, Clauss-Kobayashi, Julie, Chereau, Isabelle, D′Amato, Thierry, Dubertret, Caroline, Dubreucq, Julien, Fond, Guillaume, Laouamri, Hakim, Leignier, Sylvain, Lancon, Christophe, Llorca, Pierre-Michel, Mallet, Jasmina, Le Corvoisier, Philippe, Misdrahi, David, Passerieux, Christine, Rey, Romain, Pignon, Baptiste, Urbach, Mathieu, Szoke, Andrei, Schürhoff, Franck, Tamouza, Ryad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650073/
https://www.ncbi.nlm.nih.gov/pubmed/34901861
http://dx.doi.org/10.1093/schizbullopen/sgab012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650073/
https://www.ncbi.nlm.nih.gov/pubmed/34901861
http://dx.doi.org/10.1093/schizbullopen/sgab012

Ejemplares similares